NCT05028491View on ClinicalTrials.gov

The Influence of Meibomian Gland Expression on Corneal Aberrations in MGD Patients

CompletedOBSERVATIONAL
Enrollment

62

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

June 29, 2021

Study Completion Date

July 29, 2021

Conditions
Meibomian Gland Dysfunction
Trial Locations (1)

325027

Eye Hospital of Wenzhou Medical College, Wenzhou

All Listed Sponsors
lead

Wenzhou Medical University

OTHER

NCT05028491 - The Influence of Meibomian Gland Expression on Corneal Aberrations in MGD Patients | Biotech Hunter | Biotech Hunter